Got to acknowledge, its NOT the company's fault that there is a process for getting approved that includes time to generate the NDA and then the FDA review (6-9 months).
So I wouldn't be bashing the company at all for whats happening to the share price cause until its approved, the drug is NOT worth anything.
And its the reason why I mentioned I doubted this would see much higher before it pulls back, why some profit taking (especially if you have an account that doesn't tax you for your trades/gains now (gets you when you start withdrawing from them instead). Or consider selling covered calls to get 'something' when it peaked.
Now for me, I am not surprised to see it pullback, especially in a weak market like this. But at the same time, not surprised it ran as strongly as it did in a weak market desperate for something to buy (momentum traders). So now we will see where it bottoms out at, and I won't be surprised to see it sub $10. Just the way the market works. But imagine if you were one of the ones 'chasing and buying' when it ran up, especially the one(s) that paid up around the peak price.
Market Data 
Markets 
